These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1676091)

  • 21. [The latest progress in the pathogenesis and diagnosis of Graves' disease].
    Kimura T; Okamoto Y
    Nihon Rinsho; 2012 Nov; 70(11):1908-12. PubMed ID: 23214060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies to eye muscle and orbital fibroblasts in the pathogenesis of thyroid-associated ophthalmopathy.
    Weightman D; Perros P; Sherif I; Janat F; Kendall-Taylor P
    Exp Clin Endocrinol; 1991 May; 97(2-3):197-201. PubMed ID: 1915634
    [No Abstract]   [Full Text] [Related]  

  • 23. Bioassays for TSH-receptor autoantibodies: an update.
    Lytton SD; Kahaly GJ
    Autoimmun Rev; 2010 Dec; 10(2):116-22. PubMed ID: 20807591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune thyroid disease--a perspective.
    Volpé R
    Mol Biol Med; 1986 Feb; 3(1):25-51. PubMed ID: 2870410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?
    Kiljanski JI; Peele K; Stachura I; Pickeral J; Stolarski C; Kennerdell JS; Wall JR
    J Endocrinol Invest; 1997 Nov; 20(10):585-91. PubMed ID: 9438915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy.
    Bahn RS
    Thyroid; 2002 Mar; 12(3):193-5. PubMed ID: 11952038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TSH-receptor autoantibodies: pathophysiology, assay methods, and clinical applications.
    Ehlers M; Allelein S; Schott M
    Minerva Endocrinol; 2018 Sep; 43(3):323-332. PubMed ID: 29265783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid stimulation-blocking antibody and Graves' ophthalmopathy.
    Kubota S; Fukata S; Amino N; Miyauchi A
    Thyroid; 2006 Jul; 16(7):708. PubMed ID: 16889500
    [No Abstract]   [Full Text] [Related]  

  • 29. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid-associated eye disease.
    Heufelder AE; Joba W
    Strabismus; 2000 Jun; 8(2):101-11. PubMed ID: 10980691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are there more than antibodies to the thyroid-stimulating hormone receptor that meet the eye in Graves' disease?
    Drexhage HA
    Endocrinology; 2006 Jan; 147(1):9-12. PubMed ID: 16365140
    [No Abstract]   [Full Text] [Related]  

  • 32. Graves' disease in severe combined immunodeficient mice.
    Soliman M; Kaplan E; Straus F; Fisfalen ME; Hidaka Y; Guimaraes V; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2848-55. PubMed ID: 7559863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of radioiodine therapy on the presence of autoantibodies against human thyroid and eye muscle fractions.
    Molnár I; Balázs C
    J Endocrinol Invest; 2000 Jan; 23(1):63-4. PubMed ID: 10698054
    [No Abstract]   [Full Text] [Related]  

  • 35. Different immunophenotype and autoantibody production by peripheral blood and thyroid-derived lymphocytes in patients with Graves' disease.
    Aust G; Lehmann I; Heberling HJ
    Exp Clin Endocrinol Diabetes; 1996; 104(1):50-8. PubMed ID: 8750571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The incidence of the pituitary autoantibodies in Graves' disease].
    Gut P; Kosowicz J; Ziemnicka K; Baczyk M; Sawicka J; Czarnywojtek A; Sowiński J
    Endokrynol Pol; 2007; 58(3):195-200. PubMed ID: 17940984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease.
    Ross PV; Koenig RJ; Arscott P; Ludgate M; Waier M; Nelson CC; Kaplan MM; Baker JR
    J Clin Endocrinol Metab; 1993 Aug; 77(2):433-8. PubMed ID: 8345048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyrotropin binding inhibiting antibody (TBIAb) in Graves' disease.
    Cho WY; Choi HH; Chun HJ; Ahn IM
    Korean J Intern Med; 1988 Jan; 3(1):45-51. PubMed ID: 2908684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenetic mechanisms in thyroid-associated ophthalmopathy.
    Perros P; Kendall-Taylor P
    J Intern Med; 1992 Mar; 231(3):205-11. PubMed ID: 1556518
    [No Abstract]   [Full Text] [Related]  

  • 40. The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: the corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism.
    Kubota S; Gunji K; Ackrell BA; Cochran B; Stolarski C; Wengrowicz S; Kennerdell JS; Hiromatsu Y; Wall J
    J Clin Endocrinol Metab; 1998 Feb; 83(2):443-7. PubMed ID: 9467555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.